KJ

Khushboo Jain

Active Director Director DIN 10609946
DIN 10609946 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Khushboo Jain

Data last updated:

Khushboo Jain is a Director at Hahnemann Homoeokind Life Science Private Limited (since 2024).

DIN 10609946
Primary Designation Director
First Appointment 29 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Apr 20242024Active

Board colleagues of Khushboo Jain

NameDINCompanyDesignation
Karan Jain10609947Hahnemann Homoeokind Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hahnemann Homoeokind Life Science Private Limited
Premium access

Shareholding and investment profile for Khushboo Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khushboo Jain

Khushboo Jain currently holds 1 directorship: Hahnemann Homoeokind Life Science Private Limited (Director, since 29 Apr 2024).

Khushboo Jain was first appointed on 29 Apr 2024 as Director at Hahnemann Homoeokind Life Science Private Limited.

The current boards of Khushboo Jain's companies include Karan Jain (Hahnemann Homoeokind Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available